Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-17

Clinical Trial Update: Vitamin D Supplementation in HIV [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating Vitamin D supplementation in people with HIV infection/AIDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: HIV-infection/Aids | Phase 2, Phase 3 | Status: COMPLETED